Home Antibody All anti-NFKB1 antibodies
Also for NFKB1 (NM_003998)
|The antiserum was produced against synthesized non-phosphopeptide derived from human NF-?B p105/p50 around the phosphorylation site of serine 927 (C-D-SP-G-V).|
|WB, IHC, IF
||WB: 1:500~1:3000, IHC: 1:50~1:100, IF: 1:100~1:500, ELISA: 1:40000
|Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.|
|The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|NF-.B p105/p50 (Ab-927) antibody detects endogenous levels of total NF-.B p105/p50 protein.
|Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1), transcript variant 1|
|EBP-1; KBF1; NF-kappa-B; NF-kappaB; NF-kB1; NFkappaB; NFKB-p105; NFKB-p50; p105; p50|
MAPK signaling pathway
TGF Beta Signaling Pathway
Toll-like receptor signaling pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of extracts from Hela cells treated with TNF-a (20ng/ml, 5min), using NF-?B p105/p50 (Ab-927) antibody.The lane on the right is treated with the synthesized peptide.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using NF-?B p105/p50 (Ab-927) antibody.The picture on the right is treated with the synthesized peptide.
Immunofluorescence analysis of HeLa cells, using NF-?B p105/p50 (Ab-927) antibody.The picture on the right is treated with the synthesized peptide.